Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Journal of the American College of Cardiology
|
March 24, 2017
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial
Alessandro Sciahbasi, Enrico Frigoli, Alessandro Sarandrea, et al.
American Heart Journal
|
November 25, 2010
Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)
Dariusz Dudek, Waldemar Mielecki, Francesco Burzotta, et al.
The Journal of Allergy and Clinical Immunology
|
July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
Arinna Bertoni, Federica Penco, Hilaria Mollica, et al.
Science Translational Medicine
|
June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
Giorgia Careccia, Marielle Saclier, Mario Tirone, et al.
EMBO Molecular Medicine
|
May 6, 2021
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
Rosanna Mezzapelle, Francesco De Marchis, Chiara Passera, et al.
Blood
|
December 24, 2008
Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages
Mihai G Netea, Claudia A Nold-Petry, Marcel F Nold, et al.
The Journal of Rheumatology
|
September 17, 2017
Cryopyrin-associated Periodic Syndromes in Italian Patients: Evaluation of the Rate of Somatic NLRP3 Mosaicism and Phenotypic Characterization
Denise Lasigliè, Anna Mensa-Vilaro, Denise Ferrera, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Lancet (London, England)
|
August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
The New England Journal of Medicine
|
September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Journal of the American College of Cardiology
|
March 24, 2017
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial
Alessandro Sciahbasi, Enrico Frigoli, Alessandro Sarandrea, et al.
American Heart Journal
|
November 25, 2010
Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial)
Dariusz Dudek, Waldemar Mielecki, Francesco Burzotta, et al.
The Journal of Allergy and Clinical Immunology
|
July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment
Arinna Bertoni, Federica Penco, Hilaria Mollica, et al.
Science Translational Medicine
|
June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
Giorgia Careccia, Marielle Saclier, Mario Tirone, et al.
EMBO Molecular Medicine
|
May 6, 2021
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
Rosanna Mezzapelle, Francesco De Marchis, Chiara Passera, et al.
Blood
|
December 24, 2008
Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages
Mihai G Netea, Claudia A Nold-Petry, Marcel F Nold, et al.
The Journal of Rheumatology
|
September 17, 2017
Cryopyrin-associated Periodic Syndromes in Italian Patients: Evaluation of the Rate of Somatic NLRP3 Mosaicism and Phenotypic Characterization
Denise Lasigliè, Anna Mensa-Vilaro, Denise Ferrera, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2018
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti, Benjamin Swartzwelter, Fabia Gamboni, et al.
Lancet (London, England)
|
August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
The New England Journal of Medicine
|
September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
Marco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
Page
of 18